Skip to main content
. 2017 Mar 30;12(3):e0174503. doi: 10.1371/journal.pone.0174503

Table 2. Number and reported adverse events per 10 000 population by study site.

Adverse Events Number (Incidence /10,000)
Total N = 4563 Navrongo N = 1901 Kintampo N = 1778 Dodowa N=884
Blood and lymphatic system disorders 5 (11) 2 (11) 2 (11) 1 (11)
Cardiac disorders 2 (4) 0 (0) 2 (11) 0 (0.0)
Congenital, familial and genetic disorders 2 (4) 0 (0) 2 (11) 0 (0.0)
Eye disorders 3 (7) 2 (11) 1 (6) 0 (0.0)
Gastrointestinal disorders 47 (103) 10 (53) 13 (73) 24 (271)
General disorders and local reactions at the site of venesection 21 (46) 10 (53) 3 (17) 8 (90)
Immune system disorders 1 (2) 1 (5) 0 (0) 0 (0)
Infections and infestations 212 (465) 123 (647) 62 (349) 27 (305)
Injury, poisoning and procedural complications 2 (4) 2 (11) 0 (0) 0 (0)
Metabolism and nutrition disorders 2 (4) 2 (11) 0 (0) 0 (0)
Musculoskeletal and connective tissue disorders 9 (20) 5 (26) 0 (0) 4 (45)
Nervous system disorders 13 (28) 3 (16) 4 (22) 6 (68)
Pregnancy, puerperium and perinatal conditions 1 (2) 1 (5) 0 (0) 0 (0)
Psychiatric disorders 2 (4) 2 (11) 0 (0) 0 (0)
Renal and urinary disorders 2 (4) 1 (5) 1 (6) 0 (0)
Reproductive system and breast disorders 1 (2) 0 (0) 1 (6) 0 (0)
Respiratory, thoracic and mediastinal disorders 10 (22) 5 (26) 4 (22) 1 (11)
Skin and subcutaneous tissue disorders 12 (26) 6 (32) 3 (17) 3 (34)
Total 347 (76) 175(921) 98 (551) 74 (837)